Impact of the introduction of new vaccines and vaccine wastage rate on the cost-effectiveness of routine EPI: lessons from a descriptive study in a Cameroonian health district
Ebong, Cliford E.; Lévy, Pierre (2011), Impact of the introduction of new vaccines and vaccine wastage rate on the cost-effectiveness of routine EPI: lessons from a descriptive study in a Cameroonian health district, Cost Effectiveness and Resource Allocation, 9, 9. 10.1186/1478-7547-9-9
TypeArticle accepté pour publication ou publié
External document linkhttp://www.resource-allocation.com/content/9/1/9
Journal nameCost Effectiveness and Resource Allocation
MetadataShow full item record
Author(s)Ebong, Cliford E.
Laboratoire d'Economie de Dauphine [LEDa]
Laboratoire d'Economie et de Gestion des Organisations de Santé [Legos]
Abstract (EN)The Expanded Program of Immunization (EPI) offers services to the population free of charge but these activities are costly with the greatest part being the cost of vaccines. In spite of the growing international solidarity towards funding for immunization, the growing objectives continue to outweigh the available resources. It is therefore crucial for any immunization system to seek greater efficiency so as to optimize the use of available means in a bid to ensure sustainability. It is in this light that we carried out this study which aims to assess the productive efficiency of routine EPI for children aged 0 - 11 months with respect to the fixed and outreach vaccine delivery strategies in Ngong health district. The study is descriptive and cross-sectional. Data were collected retrospectively for all 16 health centers of the district that offered EPI services during the period February - May 2009. The results show that: • Only 62% of planned outreach immunization sessions were effectively carried out mainly due to limited funds for transportation and staff availability. Consequently vaccine coverage was low (BCG: 70.1%, DPT-HB-Hib 3: 55.5%) and less resources (43%) were used for this strategy which served 52% of the target population - a major blow to equity. • The average cost per Fully Immunized Child (FIC) was 9,571 FCFA (19.22 USD) for the fixed strategy; 12,751 FCFA (25.61 USD) for the outreach and 10,718 FCFA (21.53 USD) with both strategies combined. These figures are high than those observed in many other African health districts. However, DPT-HB-Hib and yellow fever vaccines contributed to the increase as vaccines occupied 57% of the total cost. With DPT in lieu of DPT-HB-Hib the cost/FIC would be 6,046 FCFA (12.14 USD). Dropout rates too were high (28.1% for the fixed, 29.7% for outreach). • The cost of vaccines wasted in excess of the national norm at the level of health centers was 595,532 FCFA (1,196.15 USD), an amount that could cover the vaccine cost for 122 FIC (7.6% of the FIC during the period). This was accounted for as follows: BCG 1.1%, OPV 1.4%, DPT-HB-Hib 72.7%, measles 5.3%, yellow fever 19.5% • Therefore we suggest improved communication for EPI, the introduction of DPT-HB-Hib with liquid Hib and the effective implementation of planned outreach sessions.
Subjects / KeywordsEPI (Expanded Program of Immunization); cost-effectiveness; FIC (Fully Immunized Child); Excess vaccine wastage; Pentavalent vaccine (DPT-HB-Hib); new vaccines; Cameroon; Ngong
Showing items related by title and author.
Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin Kaucley, Landry; Lévy, Pierre (2015) Article accepté pour publication ou publié
Treatment of peritonitis in France: Comparative cost-effectiveness of the association imipenem-cilastatin and other antibiotic therapy Lévy, Emile; Lévy, Pierre (1993) Article accepté pour publication ou publié
Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK Bowrin, Kevin; Briere, Jean-Baptiste; Lévy, Pierre; Millier, Aurélie; Tardu, Jean; Toumi, Mondher (2020-06) Article accepté pour publication ou publié
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France Chouaid, Christos; Bensimon, Lionel; Clay, Emilie; Millier, Aurélie; Levy-Bachelot, Laurie; Huang, Min; Lévy, Pierre (2019) Article accepté pour publication ou publié
Global optimal vaccination in the SIR model: Properties of the value function and application to cost-effectiveness analysis Laguzet, Laetitia; Turinici, Gabriel (2015) Article accepté pour publication ou publié